BIOTRONIK Excellence for Life

Join us at HRS 2025 in San Diego! We are excited to connect with you at this year’s congress on some of the biggest topics in CRM, such as Left Bundle Branch Area Pacing (LBBAP), the latest in clinic workflow optimization and future technologies.

BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features:

• RESONANCE™, the first and only multiphase stimulation paradigm
• Embrace One, a truly first-of-its-kind ecosystem that provides automatic, objective, remote daily monitoring

_{Prospera SCS System is approved in the US only and is not available outside of the US.}

_{Note: Embrace One is a support platform intended to help manage a patient’s experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment.}

BIOTRONIK’s DX Technology has reached a remarkable milestone – 100,000 DX devices implanted worldwide.¹⁴ Backed by a rich history of clinical studies since 2009, that led to extensive evidence, this accomplishment underscores our unwavering dedication to innovation and patient care.

Available as a unique, single-lead ICD system equipped with a floating atrial dipole, DX ICDs:

• offer reliable, timely information about atrial arrhythmias and detect AF early.^{2, 3, 4, 5, 6}
• help clinicians monitor AF burden over time.³

In combination with BIOTRONIK Home Monitoring^® and optionally the BIOTRONIK Patient App, this AF management solution offers a comprehensive assessment of ICD patients and enables earlier, well-informed decision-making.³